InsiderSignalSign in

← Insider buys

Thomas Patrick Kelly bought stock once, on Sep 30, 2026

Chief Financial Officer at Xenon Pharmaceuticals Inc., and 1 other company

SEC CIK 0001410514 · Filings on SEC.gov ↗

$560KBought

$6.5MSold

Oct 1Last buy

Thomas Patrick Kelly's record

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Companies

Every filing

20 filings since Jan 2019, newest first

Xenon Pharmaceuticals Inc.

Chief Financial Officer

Deciphera Pharmaceuticals, Inc.

CFO

$47K−4.0%Feb 20

Deciphera Pharmaceuticals, Inc.

CFO

$35K−4.0%Jan 18

Deciphera Pharmaceuticals, Inc.

CFO

$43K−4.0%Dec 14

Deciphera Pharmaceuticals, Inc.

CFO

$28K−4.0%Oct 31

Deciphera Pharmaceuticals, Inc.

CFO

$51K−5.0%Jan 19

Deciphera Pharmaceuticals, Inc.

CFO

$26K−3.0%Feb 18

Deciphera Pharmaceuticals, Inc.

CFO

$150K−30.0%Sep 16

Deciphera Pharmaceuticals, Inc.

CFO

$416K−56.0%Sep 10

Deciphera Pharmaceuticals, Inc.

CFO

$662K−63.0%May 13

Deciphera Pharmaceuticals, Inc.

CFO

$692K−100.0%Jan 6

Deciphera Pharmaceuticals, Inc.

CFO

$2.7M−100.0%Dec 26

Deciphera Pharmaceuticals, Inc.

CFO

$150K−100.0%Oct 30

Deciphera Pharmaceuticals, Inc.

CFO

$393K−100.0%Sep 13

Deciphera Pharmaceuticals, Inc.

CFO

$464K−100.0%Aug 13

Deciphera Pharmaceuticals, Inc.

CFO

$53K−100.0%Jun 5

Deciphera Pharmaceuticals, Inc.

CFO

$37K−100.0%May 23

Deciphera Pharmaceuticals, Inc.

CFO

$310K−100.0%May 3

Deciphera Pharmaceuticals, Inc.

CFO

$45K−100.0%Feb 20

Deciphera Pharmaceuticals, Inc.

CFO

$126K−100.0%Jan 9

Filings come from SEC EDGAR. Not investment advice.